On the other hand, recent studies in syngeneic mouse models of these cancers indicated that loss of PERK or IRE1α indeed activate anti-tumor immunity in the TME [198, 203], suggesting that UPR activation in the immune hot tumors could also promote immunosuppression. The gene discussed is ERN1; the disease is cancer.